Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NutraBella may be on hook for “fishy” bars

This article was originally published in The Tan Sheet

Executive Summary

The Standard Candy Co. of Nashville, Tenn., sues former business partner NutraBella for more than $92,000. The complaint, filed April 10 in U.S. District Court for the Middle District of Tennessee, Nashville Division, says San Mateo, Calif.-based NutraBella insisted on adding docosahexaenoic acid to its Bellybar nutritional snacks for pregnant women, despite Standard Candy's objections that it had "negative" experiences in manufacturing with the fatty acid. Standard Candy says a batch of Bellybars ended up with a "fishy" taste and NutraBella ultimately reneged on its promise to bear the costs of unusable product and ingredients. A September 2007 NutraBella release said the firm added DHA to its Bellybars "in direct response to our fans that are committed to getting ample amounts" of the fatty acid in their diet." NutraBella did not respond to a request for comment

You may also be interested in...

Singapore And Malaysia Test Joint Evaluation

A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.

Novartis And The Medicines Company: Five Things To Worry About

The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.

QUOTED. 12 December 2019. Scott Whitaker

US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts